Featured White Papers
- The missing link: Driving business results through pay-for-performance (SuccessFactors, Inc.)
- The secret to effective, no-hassle performance reviews (SuccessFactors, Inc.)
- Aug. 28th: Delivering Online Presentations That Result in Higher Sales (Citrix Online)
Health Care Industry
Industry: Email Alert RSS FeedGSK's augmentin ES-600 gets ok for acute ear infection treatment
Drug Store News, Nov 19, 2001 by James Frederick
GlaxoSmith Kline' ES-600, a version of Augmentin (amoxicillin/clavulanate potassium), has become the first antibiotic specifically indicated for tough-to-treat pediatric ear infection, GSK's anti-infectives vice president Brian Lortie said. It is approved for the treatment of children with recurrent or persistent middle ear infections due to streptococcus pneumoniae, haemohilus influenzae or moraxella catarrhalis. Children with acute otitis media may be candidates for Augmentin ES-600 if they've been given an antibiotic for middle ear infections within the preceding three months and are either 2 years of age or younger or attend daycare.
Augmentin ES-600 is an orange-raspberry powder reconstituted with water containing 600 mg of amoxicillin and 42.9 mg of clauvulanate potassium. It is given twice a day for 10 days. It is not interchangeable with regular strength Augmentin. Kids allergic to penicillin shouldn't take the drug.
COPYRIGHT 2001 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2008 Gale, Cengage Learning